EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergic Effect of the Antimicrobial Peptide ToAP2 and Fluconazole on Candida albicans Biofilms

Jhones do Nascimento Dias iD, Fabián Andrés Hurtado Erazo iD, Lucinda J Bessa iD, Peter Eaton iD, José Roberto de Souza de Almeida Leite iD, Hugo Costa Paes, André Moraes Nicola iD, Ildinete Silva-Pereira iD, Patrícia Albuquerque iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25147769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jhones do Nascimento Dias und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology of Fungi, University of Brasilia, Brasilia 70910-900, Brazil. Hauptthemen laut MEDLINE: Biofilms, Fluconazole, Candida albicans, Drug Synergism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Foundation for Research Support of the Federal District, Fundação de Apoio à Pesquisa do Distrito Federal (FAP-DF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candida albicans is one of the agents of invasive candidiasis, a life-threatening disease strongly associated with hospitalization, particularly among patients in intensive care units with central venous catheters. This study aimed to evaluate the synergistic activity of the antifungal peptide ToAP2 combined with fluconazole against C. albicans biofilms grown on various materials. We tested combinations of different concentrations of the peptide ToAP2 with fluconazole on C. albicans biofilms. These biofilms were generated on 96-well plates, intravenous catheters, and infusion tubes in RPMI medium at two maturation stages. Scanning electron microscopy and atomic force microscopy were employed to assess the biofilm structure. We also evaluated the expression of genes previously proven to be involved in C. albicans biofilm formation in planktonic and biofilm cells after treatment with the peptide ToAP2 using qPCR. ToAP2 demonstrated a synergistic effect with fluconazole at concentrations up to 25 µM during both the early and mature stages of biofilm formation in 96-well plates and on medical devices. Combinations of 50, 25, and 12.5 µM of ToAP2 with 52 µM of fluconazole significantly reduced the biofilm viability compared to individual treatments and untreated controls. These results were supported by substantial structural changes in the biofilms observed through both scanning and atomic force microscopy. The gene expression analysis of C. albicans cells treated with 25 µM of ToAP2 revealed a decrease in the expression of genes associated with membrane synthesis, along with an increase in the expression of genes involved in efflux pumps, adhesins, and filamentation. Our results highlight the efficacy of the combined ToAP2 and fluconazole treatment against C. albicans biofilms. This combination not only shows therapeutic potential but also suggests its utility in developing preventive biofilm tools for intravenous catheters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsFluconazoleCandida albicansDrug SynergismAntifungal AgentsAntimicrobial PeptidesMicrobial Sensitivity TestsHumansMicroscopy, Atomic ForceGene Expression Regulation, FungalFungal Proteins

Stichwörter der Autor:innen

Candida albicansantifungal drugsantimicrobial peptidesbiofilmsfluconazolesynergism

Substanzen

FluconazoleAntifungal AgentsAntimicrobial PeptidesFungal Proteins

Autor:innen und Institutionen

  • Laboratory of Molecular Biology of Fungi, University of Brasilia, Brasilia 70910-900, Brazil.
  • LAQV/REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.
  • The Bridge, School of Chemistry, University of Lincoln, Lincoln LN6 7TS, UK.
  • Center for Research in Applied Morphology and Immunology, NuPMIA, University of Brasilia, Brasilia 70910-900, Brazil.
  • Faculty of Medicine, University of Brasilia, Brasilia 70910-900, Brazil.

ORCID-Profile: Jhones do Nascimento Dias, Fabián Andrés Hurtado Erazo, Lucinda J Bessa, Peter Eaton, José Roberto de Souza de Almeida Leite, André Moraes Nicola, Ildinete Silva-Pereira, Patrícia Albuquerque

Förderung

  • National Council for Scientific and Technological Development
  • Foundation for Research Support of the Federal District
  • Fundação de Apoio à Pesquisa do Distrito Federal (FAP-DF)

Zitieren

APA

do Nascimento Dias, J., Hurtado Erazo, F. A., Bessa, L. J., Eaton, P., Leite, J. R. S. A., Paes, H. C., Nicola, A. M., Silva-Pereira, I., & Albuquerque, P. (2024). Synergic Effect of the Antimicrobial Peptide ToAP2 and Fluconazole on Candida albicans Biofilms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147769

Vancouver

do Nascimento Dias J, Hurtado Erazo FA, Bessa LJ, Eaton P, Leite JRSA, Paes HC, et al. Synergic Effect of the Antimicrobial Peptide ToAP2 and Fluconazole on Candida albicans Biofilms. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147769

BibTeX
@article{doNascimentoDias2024,
  author = {do Nascimento Dias, Jhones and Hurtado Erazo, Fabián Andrés and Bessa, Lucinda J and Eaton, Peter and Leite, José Roberto de Souza de Almeida and Paes, Hugo Costa and Nicola, André Moraes and Silva-Pereira, Ildinete and Albuquerque, Patrícia},
  title = {Synergic Effect of the Antimicrobial Peptide ToAP2 and Fluconazole on Candida albicans Biofilms},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25147769}
}
Kostenlos starten →